UCL picks ViroCell as partner for childhood cancer treatment

ViroCell Biologics, a London-based viral vector CDMO for cell and gene therapy clinical trials, has partnered with University College London (UCL) to advance its pediatric cancer treatment.

Related Keywords

United Kingdom ,Farzin Farzaneh ,Persis Amrolia ,Regulatory Agency ,Zayed Centre For Research ,Professor Amrolia ,United Kingdom Medicines ,Great Ormond Street Hospital ,Zayed Centre ,Bio Developments ,Markets Amp Regulations ,Emerging Markets ,Cell Amp Gene Therapies ,Dancer ,Ncology ,Dmo ,Cell And Gene Therapy ,